Family · Pharmaceutical analytical standards
Clozapine
An antipsychotic synthesised in Switzerland in 1958 and the founder of the atypical antipsychotics; approved in the United States in 1989, it is reserved for schizophrenia that does not respond to other treatments. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?At first many psychiatrists doubted it worked, because it did not cause stiffness and tremor: a true antipsychotic was believed to need them. This very difference is why it was called 'atypical'.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
